Kanwal Khalid

490 citations
9 papers · 306 · 1 hit paper · h-index 5

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA Interference and Gene Delivery
    • vaccines and immunoinformatics approaches
    • RNA modifications and cancer
    • Extracellular vesicles in disease

Papers in

    • vaccines and immunoinformatics approaches 7
    • RNA Interference and Gene Delivery 1
    • SARS-CoV-2 and COVID-19 Research 6
    • Viral gastroenteritis research and epidemiology 3

Kanwal Khalid

9 papers receiving 303 citations

Kanwal Khalid's Hit Papers

miRNA: A Promising Therapeutic Target in Cancer 2022 · 211 citations
2110+1+2Years since publication50100150200

Peers

Kanwal Khalid
Comparison fields: 5 of 62
  • Cancer Research 159
  • Molecular Biology 221
  • Infectious Diseases 53
  • Molecular Medicine 14
  • Health 12
Replace Chuangeng Chen with:
Chuangeng Chen China
Daowei Yang China
Congle Shen China
Javier T. Granados-Riverón Mexico
Anne Le Bouter France
Tomoka Nakamura United States
Shujuan Du China
Paola Guerriero Italy
Amaia González‐Magaña Spain
Cheng-Yao Li China
Kanwal Khalid relative to Chuangeng Chen China Chuangeng Chen's profile →
Citations per field
00.5×
Chuangeng Chen · 1×
Citations per year

Countries citing papers authored by Kanwal Khalid

Since Specialization
Citations

This map shows the geographic impact of Kanwal Khalid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanwal Khalid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanwal Khalid more than expected).

Fields of papers citing papers by Kanwal Khalid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanwal Khalid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanwal Khalid. The network helps show where Kanwal Khalid may publish in the future.

Co-authors

The 10 scholars most cited alongside Kanwal Khalid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kanwal Khalid Line = papers co-authored together Kanwal Khalid links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
miRNA: A Promising Therapeutic Target in Cancer
Hit paper breakdown →
2022211
2 202344
3 202317
4 202313
5 202213
6 20254
7 20252
8 20241
9 20241

About Kanwal Khalid

Kanwal Khalid is a scholar working on Molecular Biology, Infectious Diseases, Immunology, Critical Care and Intensive Care Medicine and Health, having authored 9 papers that have together received 306 indexed citations. Recurring topics across this work include vaccines and immunoinformatics approaches (7 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Viral gastroenteritis research and epidemiology (3 papers), Immunotherapy and Immune Responses (2 papers), RNA Interference and Gene Delivery (1 paper), Long-Term Effects of COVID-19 (1 paper), MicroRNA in disease regulation (1 paper) and Vaccine Coverage and Hesitancy (1 paper). The work is most often cited by research in Cancer Research (159 citations), Molecular Biology (221 citations), Infectious Diseases (53 citations), Molecular Medicine (14 citations) and Health (12 citations). Kanwal Khalid has collaborated with scholars based in Malaysia, China and Singapore. Frequent co-authors include Chit Laa Poh, Rakesh Naidu, Noraini Abd-Aziz, Hui Xuan Lim, Malihe Masomian, Paul A. MacAry, Ayaz Anwar, Learn−Han Lee, Raja Affendi Raja Ali and Jung Shan Hwang. Their work appears in journals such as International Journal of Molecular Sciences, AAPS PharmSciTech, Biomedicine & Pharmacotherapy, Vaccines and Viruses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact